Related Experiment Videos
Nasal mucociliary clearance and salmeterol
1Department of Otolaryngology, Ninewells Hospital, Dundee, UK.
Clinical Otolaryngology and Allied Sciences
|February 1, 1997
Summary
Salmeterol, a beta 2-adrenergic agent, significantly improved nasal mucociliary clearance in healthy adults. This topical spray reduced nasal transport time by 21% compared to placebo, suggesting a potential therapeutic benefit.
Area of Science:
- Respiratory Physiology
- Pharmacology
Background:
- In vitro studies indicate beta 2-adrenergic agents can enhance ciliary beat frequency in human respiratory epithelium.
- Nasal mucociliary clearance is a critical defense mechanism of the respiratory tract.
Purpose of the Study:
- To evaluate the efficacy of a topical salmeterol spray on nasal mucociliary clearance in healthy adults.
- To determine if salmeterol affects nasal mucociliary transport time in a randomized, double-blind, placebo-controlled setting.
Main Methods:
- A randomized, double-blind, placebo-controlled trial was conducted.
- Thirty-three healthy adults participated, receiving either salmeterol or placebo spray.
- Nasal mucociliary clearance was assessed using the saccharin test to measure transport time.
Main Results:
- Salmeterol spray resulted in a 21% reduction in nasal mucociliary transport time compared to placebo (P = 0.0001).
- No significant influence of age, sex, treatment order, spray-to-test interval, or allergic rhinitis history was observed on clearance improvement.
Conclusions:
- Topical salmeterol spray effectively enhances nasal mucociliary clearance in healthy individuals.
- The findings support the potential of beta 2-adrenergic agents delivered topically for improving respiratory tract clearance mechanisms.